The current study objectives were to systematically review all published English and Persian studies of the prevalence of methamphetamine use, the general physical and psychiatric-related harms and the availability of methamphetamine treatment and harm reduction services for adult users in Iran.
With the paucity of new agents targeting AHFS (most of them challenged with questionable long-term safety profiles), the availability of evidence showing the lack of harm with add-on tolvaptan represents valuable and reassuring information for its use in this patient population.
However, availability of harm reduction programmes has remained low.
The present study was designed to assess the acceptability and availability of harm-reduction interventions, including needle exchange, education regarding safer drug-ingestion methods, complementary/alternative therapies, and safe places where problem drinkers and drug takers may stay after consumption or may consume substances on the premises.
"The appearance of bars on our motorway network adds greater urgency to the Alcohol Health Alliance's call for a fundamental review of licensing laws, focusing on the availability of alcohol and reducing alcohol-related harm.
Considering the potential for harm and the availability of other drugs to prevent postoperative nausea and vomiting, we recommend that steroids should be used with caution; risks and benefits must be weighted; and steroids should not be used routinely for such purposes, especially in children.
A preassessment conversation with the CNS covering, the reason for recall, the assessment process including possible harms, and the availability of the CNS for a debrief after the assessment whatever the outcome.
Three items (quantification of benefits, the availability of treatment or diagnostic options, and description of harms associated with the intervention) showed significant improvements over the duration of the study (p = 0.007, p = 0.019, p = 0.0005 respectively).
Statistically significant improvements were seen in coverage of the potential harms of interventions, the availability of treatment or diagnostic options, and accurate quantification of benefits.
These experts suggested that consumers be educated about the availability of screening, encouraged to understand benefits and harms, then asked to carefully consider whether or not the program was right for them.
